A Rare Case of Fatal Toxic Epidermal Necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient with Rheumatoid Arthritis [0.03%]
一例罕见的类风湿关节炎患者中毒性表皮坏死松解症(TEN)和药物反应伴嗜酸性粒细胞增多及系统症状(DRESS)综合征致死病例
Renuka Munshi,Praneet Sachdeo,Vikas Solanki
Renuka Munshi
Introduction: This case study presents a rare and fatal instance of Toxic Epidermal Necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome in a 51-year-old male patient diagnosed with ...
DRESS Mimicking Flushing Syndrome Associated with Vancomycin: A Case Report [0.03%]
万古霉素相关性类 flushing 综合征的 1 例报道
Sanjeev Khanth P E,Pugazhenthan Thangaraju,Nitin R Gaikwad et al.
Sanjeev Khanth P E et al.
Background: The Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a serious adverse reaction that occurs weeks after the onset of drug exposure. DRESS syndrome is commonly associated with antiseizure drugs,...
Adverse Events Associated with Antivirals for COVID-19: An Analysis Based on FDA Adverse Event Reporting System (FAERS) [0.03%]
基于美国食品药品监督管理局不良事件报告系统(FAERS)的抗新冠病毒药物的不良反应分析
Muhammad Ikhwan Syahmi Mohamad Radzuan,Mahmathi Karuppannan
Muhammad Ikhwan Syahmi Mohamad Radzuan
Background: The COVID-19 pandemic has called for the rapid development and use of antiviral drugs to effectively control the disease. Nirmatrelvir/Ritonavir (Paxlovid), Molnupiravir, and Remdesivir have been pivotal in th...
Mycophenolate Mofetil Induced-Colitis: Is it More about Clinical Diagnosis? [0.03%]
霉酚酸酯诱导结肠炎：是否更多是临床诊断问题？
Yoghini Nagandran,Saikat Mandal,Ayuni Zahirah Zahar
Yoghini Nagandran
Background: Mycophenolate mofetil (MMF) is an immunosuppressant commonly used for treating autoimmune diseases. Case presentation: We r...
The Presence of Nitrosamines and Nitrosamine Drug-Related Substances in Pharmaceutical Products: An Overview of Regulatory Concerns, Analytical Methodologies, and Control Strategies [0.03%]
药物中的亚硝胺和与药品相关的亚硝胺物质的存在：监管关注、分析方法及控制策略概述
Neha Dhansekar,Pratiksha Rale,Yogesh Ghalsasi
Neha Dhansekar
The presence of N-nitrosamine impurities in pharmaceutical products is well known. In 2019, it resulted in drug recall by the Food and Drug Administration (FDA). Soon, several groups identified the presence of many N-nitrosamines (NAs) in v...
Vorasidenib: A Milestone in Targeted Therapy for IDH-Mutant Lower Grade Gliomas - Efficacy, Emerging Safety Concerns, and the Call for Comprehensive Safety Evaluation [0.03%]
伏格列汀：IDH突变低级别胶质瘤靶向治疗的里程碑——疗效、新出现的安全性问题及全面安全性评估的呼吁
Beema T Yoosuf,Manisa Pattanayak,Sanjit Sah
Beema T Yoosuf
SGLT-2 Inhibitors as an Effective Treatment for Type 2 Diabetes Mellitus, Hypertension, and Hyperuricemia - A Mechanistic Perspective [0.03%]
从机制角度探究钠葡萄糖协同转运蛋白-2抑制剂在2型糖尿病、高血压和高尿酸血症治疗中的有效作用
Sultan Al Rashid,Rajkapoor Balasubramanian,Naina Mohamed Pakkir Maideen
Sultan Al Rashid
Carbamazepine-induced Stevens-Johnson Syndrome: A Case Report with Review of the Literature [0.03%]
卡马西平致斯蒂文斯-约翰逊综合征1例及相关文献复习
Arunkumar Subramanian,Rajamohamed Haitharali,Nirenjen S et al.
Arunkumar Subramanian et al.
Background: Stevens-Johnson Syndrome (SJS) is an infrequent yet severe mucocutaneous reaction that involves less than 10% of the Body Surface Area (BSA). It is predominantly induced by certain medications, including antic...
Mahjoubi Yasmine Salem,Aouinti Imen,Dahmani Israa et al.
Mahjoubi Yasmine Salem et al.
Background: Tumor necrosis factor alpha (TNF-α) inhibitors, such as adalimumab, have significantly advanced the treatment of inflammatory diseases. However, these therapies are associated with various cutaneous adverse r...
Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of Weight Loss; A Systematic Review [0.03%]
tirzepatide在体重管理中的作用：系统性综述
Imran Rashid Rangraze,Shehla Khan,Adil Farooq Wali et al.
Imran Rashid Rangraze et al.
Aim: The eventuality of tirzepatide, a binary GIP and GLP- 1 receptor agonist, as a treatment for rotundity and metabolic diseases is addressed in this comprehensive review. ...